TY - JOUR T1 - Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01636-2018 SP - 1801636 AU - Seong Mi Moon AU - Byung Woo Jhun AU - Charles L. Daley AU - Won-Jung Koh Y1 - 2019/01/01 UR - http://erj.ersjournals.com/content/early/2019/02/20/13993003.01636-2018.abstract N2 - The incidence and prevalence of nontuberculous mycobacterial pulmonary disease (NTM-PD) are increasing worldwide [1, 2]. NTM-PD treatment is challenging due to long-term, multiple antibiotic therapy and poor treatment outcomes [3, 4]. Standardised treatment outcome definitions for NTM-PD were recently reported in the Nontuberculous Mycobacteria Network European Trials Group (NTM-NET) consensus statement [5], an important development for patient management and clinical research [5].FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.Conflict of interest: Dr. Moon has nothing to disclose.Conflict of interest: Dr. Jhun has nothing to disclose.Conflict of interest: Dr. Daley reports grants and personal fees from Insmed, personal fees from Horizon, personal fees from Spero, personal fees from Johnson and Johnson, outside the submitted work.Conflict of interest: Dr. Koh reports personal fees from Insmed Inc., outside the submitted work. ER -